Veterinary Care Market for Asia and Latin America Worth USD 23 and USD 9 billion, by 2025 - Leading Companies are Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France

According to the new market research report "Veterinary Care Market by Treatment Type (No medicalization, Basic Medicalization, and Under Long Term Veterinary Care), Animal Type (Dogs, Cats, Cattle, Horses, Pigs, and Poultry), and Region - Forecasts to 2025 ", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in Europe, Latin America, Asia Pacific, and Africa.

The veterinary care market is predicted to grow considerably during the forecast period. Factors such as rising pet ownership trends, increasing government initiative as well as the growing availability of superior quality veterinary products and services, should foster market growth. Moreover, positive trends for the market can be observed through the animal health care market that has been parallelly growing at a faster rate.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78396315#utm_source=Openpr&utm_medium=paidpr

For instance, the Asian animal health market is growing at around 5.2%, and the market is predicted to reach USD 23 billion in 2025. Similarly, there are tremendous growth opportunities for the animal health market in Latin American countries due to improving regulatory scenarios. Latin America animal health market is expected to reach USD 9 billion by 2025 from USD 5.2 billion in 2018, at a CAGR of 7.3% during the forecast period. Taking into consideration the fact that animal health is improving in developing regions, it is evident that the veterinary care market will continue to grow in these countries.

By treatment type, the basic medicalization segment is expected to foresee considerable growth during the forecast period.

Based on treatment type, the market has been segmented into non-medicalized, basic medicalization, and under veterinary care. Amongst the treatment type category, the basic medicalization segment will have significant growth. The segment growth is attributable to the rising awareness regarding the pet as well as farm owners regarding animal preventive health. Moreover, the animal welfare authorities also take efforts to ensure maximum preventive health amongst the companion and the food-producing animals that prove beneficial for the segmental growth.

Browse and in-depth TOC on "Veterinary Care Market"
62 - Tables
50 - Figures
76 - Pages
Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=78396315#utm_source=Openpr&utm_medium=paidpr

By animal type, dogs will receive maximum preventive health

Based on animal type, the veterinary care market has been segmented into dogs, cats, horses, cattle, pigs, and poultry. Dogs amongst the other companion animals are predicted to receive the utmost preventive as well as the long term veterinary care. Pet owners in developed and developing regions often consider pets as their companions and, therefore, provide them with necessary medicalization. Furthermore, authorities involved in animal welfare also create provisions for stray animals that will positively impact segmental growth.

Eastern European countries have positive veterinary care trends throughout the forecast years

European countries experience positive trends regarding veterinary care since the animal owners follow all the animal welfare laws and regulations sincerely. The regional growth can also be associated with the increasing number of veterinarians and clinics in European countries.

Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=78396315#utm_source=Openpr&utm_medium=paidpr

Key Players

The prominent players in the veterinary care market include Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France), IDEXX Laboratories, Inc., Neogen Corporation (US), Heska Corporation (US) and others. These players have undertaken several initiatives to capture significant market share.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's™ flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.